Sarah K. Brode

2.5k total citations
55 papers, 960 citations indexed

About

Sarah K. Brode is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Sarah K. Brode has authored 55 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Epidemiology, 42 papers in Infectious Diseases and 17 papers in Surgery. Recurrent topics in Sarah K. Brode's work include Tuberculosis Research and Epidemiology (41 papers), Mycobacterium research and diagnosis (40 papers) and Infectious Diseases and Mycology (17 papers). Sarah K. Brode is often cited by papers focused on Tuberculosis Research and Epidemiology (41 papers), Mycobacterium research and diagnosis (40 papers) and Infectious Diseases and Mycology (17 papers). Sarah K. Brode collaborates with scholars based in Canada, United States and Japan. Sarah K. Brode's co-authors include Theodore K. Marras, Charles L. Daley, Alex Marchand‐Austin, Frances Jamieson, Jeffrey C. Kwong, Michael A. Campitelli, Kenneth R. Chapman, Simon C. Ling, Hong Lu and Andrea S. Gershon and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

Sarah K. Brode

51 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah K. Brode Canada 15 693 514 235 183 168 55 960
Hideo Ogata Japan 15 613 0.9× 535 1.0× 133 0.6× 112 0.6× 247 1.5× 77 884
Steven Cowman United Kingdom 11 432 0.6× 274 0.5× 180 0.8× 314 1.7× 69 0.4× 18 730
Kazuma Yagi Japan 17 427 0.6× 278 0.5× 109 0.5× 232 1.3× 81 0.5× 57 812
Masoud Shamaei Iran 16 301 0.4× 307 0.6× 50 0.2× 116 0.6× 161 1.0× 39 611
Akio Niimi Japan 12 393 0.6× 358 0.7× 225 1.0× 387 2.1× 122 0.7× 32 865
Evelyne Le Roux France 9 357 0.5× 214 0.4× 181 0.8× 202 1.1× 68 0.4× 14 577
U Greinert Germany 14 516 0.7× 578 1.1× 39 0.2× 134 0.7× 369 2.2× 35 812
R. Adams United States 9 488 0.7× 520 1.0× 62 0.3× 129 0.7× 46 0.3× 12 833
Noriyuki Horiki Japan 17 134 0.2× 163 0.3× 49 0.2× 331 1.8× 516 3.1× 92 1.0k
P Tukiainen Finland 18 322 0.5× 132 0.3× 35 0.1× 753 4.1× 142 0.8× 55 1.1k

Countries citing papers authored by Sarah K. Brode

Since Specialization
Citations

This map shows the geographic impact of Sarah K. Brode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah K. Brode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah K. Brode more than expected).

Fields of papers citing papers by Sarah K. Brode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah K. Brode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah K. Brode. The network helps show where Sarah K. Brode may publish in the future.

Co-authorship network of co-authors of Sarah K. Brode

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah K. Brode. A scholar is included among the top collaborators of Sarah K. Brode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah K. Brode. Sarah K. Brode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yan, Marie, Kamila Romanowski, Sarah K. Brode, et al.. (2025). Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases. 81(1). 119–128. 3 indexed citations
3.
Puyat, Joseph H., Sarah K. Brode, Hennady P. Shulha, et al.. (2024). Predicting Risk of Tuberculosis (TB) Disease in People Who Migrate to a Low-TB Incidence Country: Development and Validation of a Multivariable, Dynamic Risk-Prediction Model Using Health Administrative Data. Clinical Infectious Diseases. 80(3). 644–652. 1 indexed citations
4.
Yan, Marie, Sarah K. Brode, & Theodore K. Marras. (2023). Treatment of the Less Common Nontuberculous Mycobacterial Pulmonary Disease. Clinics in Chest Medicine. 44(4). 799–813. 4 indexed citations
6.
8.
Brode, Sarah K., et al.. (2021). Time to Positive Culture Detection Predicts Mycobacterium avium Pulmonary Disease Severity and Treatment Initiation. Annals of the American Thoracic Society. 19(6). 925–932. 7 indexed citations
9.
Marras, Theodore K., et al.. (2021). Aspergillus isolation in nontuberculous mycobacterial pulmonary disease: Associated with antimycobacterial treatment initiation but not response. Respiratory Medicine. 179. 106338–106338. 2 indexed citations
10.
Ramsay, Lauren, John Wang, Theodore K. Marras, et al.. (2020). Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012. Emerging infectious diseases. 26(9). 2097–2107. 8 indexed citations
11.
Hirama, Takashi, et al.. (2020). Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016. Canada Communicable Disease Report. 46(4). 84–92. 7 indexed citations
12.
Hirama, Takashi, Alex Marchand‐Austin, Jennifer Ma, et al.. (2018). Mycobacterium xenopi Genotype Associated with Clinical Phenotype in Lung Disease. Lung. 196(2). 213–217. 6 indexed citations
13.
Aznar, María Luisa, et al.. (2018). Safety and effectiveness of clofazimine in nontuberculous mycobacterial lung disease. Canadian Journal of Respiratory Critical Care and Sleep Medicine. 2(2). 72–77. 5 indexed citations
14.
Brode, Sarah K., Alex Marchand‐Austin, Frances Jamieson, & Theodore K. Marras. (2017). Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada. Emerging infectious diseases. 23(11). 1898–1901. 62 indexed citations
15.
Marras, Theodore K., Michael A. Campitelli, Hong Lu, et al.. (2017). Pulmonary Nontuberculous Mycobacteria–Associated Deaths, Ontario, Canada, 2001–2013. Emerging infectious diseases. 23(3). 468–476. 58 indexed citations
16.
Khoo, Edwin, Sarah K. Brode, Frances Jamieson, et al.. (2016). Health‐related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review. Respirology. 21(6). 1015–1025. 25 indexed citations
17.
Brode, Sarah K., F. Jamieson, Ryan Ng, et al.. (2015). Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax. 70(7). 677–682. 112 indexed citations
18.
Brode, Sarah K., Frances Jamieson, Ryan Ng, et al.. (2013). Population-Based Risk of Mycobacterial Infections Associated With Anti-Tumor Necrosis Factor (anti-TNF) Therapy in Older Patients in Ontario, Canada. CHEST Journal. 144(4). 270A–270A. 1 indexed citations
19.
Johnson, Sindhu R., Sarah K. Brode, Lisa Mielniczuk, & John Granton. (2012). Dual therapy in IPAH and SSc-PAH. A qualitative systematic review. Respiratory Medicine. 106(5). 730–739. 23 indexed citations
20.
Heath, Daniel D., et al.. (2006). Population structure and divergence using microsatellite and gene locus markers in Chinook salmon (Oncorhynchus tshawytscha) populations. Canadian Journal of Fisheries and Aquatic Sciences. 63(6). 1370–1383. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026